Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon A Smith

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Bioresource Technology|August 6, 2010
Self-consistent liquid-to-gas mass transfer calculationsSimon A Smith, Claudio O Stöckle
Bioresource Technology|April 22, 2008
A biogas meter with adjustable resolution and minimal back-pressureSimon A Smith, Claudio O Stöckle
The Journal of Pathology|October 12, 2013
The impact of germline mutations on targeted therapySimon A Smith, Tim French, Simon J Hollingsworth
Gynecologic Oncology|April 26, 2002
Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group studyMark Reedy, Holly Gallion, Jeffrey M Fowler, et al.
Toxicology and Applied Pharmacology|February 16, 2016
The value of integrating pre-clinical data to predict nausea and vomiting risk in humans as illustrated by AZD3514, a novel androgen receptor modulatorClaire Grant, Lorna Ewart, Daniel Muthas, et al.
FEMS Microbiology Letters|July 26, 2005
The nematode Panagrellus redivivus is susceptible to killing by human pathogens at 37 degrees CThomas R Laws, Simon A Smith, Martin P Smith, et al.
International Journal of Experimental Pathology|February 28, 2013
Experimental respiratory Marburg virus haemorrhagic fever infection in the common marmoset (Callithrix jacchus)Sophie J Smither, Michelle Nelson, Lin Eastaugh, et al.
Chemical Communications (Cambridge, England)|February 15, 2013
Fluorogenic dansyl-ligated gold nanoparticles for the detection of sulfur mustard by displacement assayRichard C Knighton, Mark R Sambrook, Jack C Vincent, et al.
Cancer|October 16, 2023
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancerSehhoon Park, Yu Jung Kim, Young Joo Min, et al.
Cancer|June 26, 2020
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapySehhoon Park, Joonho Shim, Peter G S Mortimer, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Bioresource Technology|August 6, 2010
Self-consistent liquid-to-gas mass transfer calculationsSimon A Smith, Claudio O Stöckle
Bioresource Technology|April 22, 2008
A biogas meter with adjustable resolution and minimal back-pressureSimon A Smith, Claudio O Stöckle
The Journal of Pathology|October 12, 2013
The impact of germline mutations on targeted therapySimon A Smith, Tim French, Simon J Hollingsworth
Gynecologic Oncology|April 26, 2002
Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group studyMark Reedy, Holly Gallion, Jeffrey M Fowler, et al.
Toxicology and Applied Pharmacology|February 16, 2016
The value of integrating pre-clinical data to predict nausea and vomiting risk in humans as illustrated by AZD3514, a novel androgen receptor modulatorClaire Grant, Lorna Ewart, Daniel Muthas, et al.
FEMS Microbiology Letters|July 26, 2005
The nematode Panagrellus redivivus is susceptible to killing by human pathogens at 37 degrees CThomas R Laws, Simon A Smith, Martin P Smith, et al.
International Journal of Experimental Pathology|February 28, 2013
Experimental respiratory Marburg virus haemorrhagic fever infection in the common marmoset (Callithrix jacchus)Sophie J Smither, Michelle Nelson, Lin Eastaugh, et al.
Chemical Communications (Cambridge, England)|February 15, 2013
Fluorogenic dansyl-ligated gold nanoparticles for the detection of sulfur mustard by displacement assayRichard C Knighton, Mark R Sambrook, Jack C Vincent, et al.
Cancer|October 16, 2023
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancerSehhoon Park, Yu Jung Kim, Young Joo Min, et al.
Cancer|June 26, 2020
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapySehhoon Park, Joonho Shim, Peter G S Mortimer, et al.
Pageof 2